Clik here to view.
武田宣布美国存托股票在纽约证券交易所上市
日本大阪 (美国商业资讯)–如在任何司法管辖区内直接或间接发布、出版或分发全部或部分内容构成违反该司法管辖区有关法律的行为，则不得在此等司法管辖区从事该行为。 武田药品工业株式会社(TSE:...
View ArticleClik here to view.
武田薬品がニューヨーク証券取引所への米国預託株式の上場を発表
大阪 （ビジネスワイヤ） — 本情報の全部または一部の直接的または間接的な公開、出版、配布が関係する法律の違反となる国・地域においては、そのような公開、出版、配布を禁止します。...
View ArticleClik here to view.
Astellas and Pfizer Announce Positive Top-Line Results from Phase 3 ARCHES...
TOKYO & NEW YORK Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Pfizer Inc. (NYSE: PFE) today announced that the Phase 3 ARCHES trial evaluating...
View ArticleClik here to view.
ティルレイが一流製薬企業との世界的協業契約を締結
加ブリティッシュコロンビア州ナナイモ （ビジネスワイヤ） — 医療用カンナビスの生産・研究・販売の世界的パイオニアであるティルレイ（NASDAQ:...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Launches Aspirin and Extended-Release Dipyridamole...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY), along with its subsidiaries together referred to as “Dr. Reddy’s”, today announced the...
View ArticleClik here to view.
ヘンリーシャインとヴェッツ・ファースト・チョイスが予定している新会社の名称を発表：Covetrus
米ニューヨーク州メルビル & メーン州ポートランド （ビジネスワイヤ） — ヘンリーシャイン（Nasdaq: HSIC）とヴェッツ・ファースト・チョイスは本日、ヘンリーシャインの動物医療事業部のスピンオフとその後のヴェッツ・ファースト・チョイスとの合併によって生まれる新たな独立した公開会社の名称がCovetrusになると発表しました。...
View ArticleClik here to view.
汉瑞祥和Vets First Choice宣布，依计划产生的新公司命名为Covetrus
纽约州梅尔维尔和缅因州波特兰 (美国商业资讯)–汉瑞祥公司(Henry Schein, Inc.; Nasdaq: HSIC)和Vets First Choice今天宣布，依计划从Henry Schein Animal Health业务分拆并随后与Vets First Choice合并而产生的新的独立上市公司将命名为Covetrus。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
PHCホールディングス株式会社：米国・糖尿病技術学会において、アセンシアの血糖自己測定システム用アプリケーション「CONTOUR®...
東京 （ビジネスワイヤ） — PHCホールディングス株式会社（本社：東京都港区、代表取締役社長：小谷 秀仁）の100％子会社であるアセンシア ダイアベティスケアホールディングス株式会社（本社：スイス、バーゼル、以下「アセンシア」）は、このたび、第28回米国・糖尿病技術学会において、同社が海外市場向けに販売する血糖自己測定システム用アプリケーション「CONTOUR®...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Announces the Launch of Sevelamer Carbonate for Oral...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the...
View ArticleClik here to view.
VivaGel® Condom Receives Final Regulatory Approval in Japan
MELBOURNE, Australia Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that the VivaGel® condom has received final regulatory approval and is now able to be marketed in Japan, following the...
View ArticleClik here to view.
Promethera Biosciences Announces Investment by ITOCHU Corporation and a Broad...
MONT-SAINT-GUIBERT, Belgium & TOKYO Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, today announced a strategic investment of EUR10 million by ITOCHU...
View ArticleClik here to view.
Cardiovascular Systems, Inc. Receives Approval for the Diamondback 360®...
ST. PAUL, Minn. Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral...
View ArticleClik here to view.
Gynesonics Announces $75 Million Financing
REDWOOD CITY, Calif. Gynesonics, a women’s healthcare company and the developer of the Sonata System and other advanced, incision-free solutions for the treatment of uterine conditions, today...
View ArticleClik here to view.
Thousand Oaks Biopharmaceuticals Completes $45 Million Series A Financing to...
THOUSAND OAKS, Calif. & SHANGHAI Thousand Oaks Biopharmaceuticals, Inc. (“TOBIO”), a leading integrated global CMC organization including GMP cell culture media and biomanufacturing capabilities...
View ArticleClik here to view.
1ST Biotherapeutics and twoXAR Form Co-Development Collaboration to Discover...
SEONGNAM, South Korea & MOUNTAIN VIEW, Calif. 1ST Biotherapeutics, Inc., a preclinical-stage biotechnology company focused on neurodegenerative diseases, immuno-oncology, and orphan diseases,...
View ArticleClik here to view.
Takeda Announces Multiple Cell Therapy Collaborations to Advance the...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (“Takeda”) (TSE: 4502) today announced new research collaborations in immuno-oncology (I-O), an area of key strategic focus...
View ArticleClik here to view.
Takeda Notes Court Sanction of the Scheme of Arrangement with Respect to the...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) notes Shire plc’s (“Shire”) announcement that the Royal Court of Jersey (the “Jersey Court”) has today sanctioned...
View ArticleClik here to view.
CES 2019 Pitch Competition Featuring Shark Tank’s Daymond John Presented by...
LAS VEGAS The first annual CES Pitch Competition to highlight technology creating social connection was announced today by the Consumer Technology Association (CTA) Foundation and AARP. Kicking off...
View ArticleClik here to view.
GI Dynamics Appoints Vice President of Clinical and Regulatory Affairs
BOSTON & SYDNEY GI Dynamics® Inc. (ASX:GID), a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, is pleased to announce the appointment of...
View ArticleClik here to view.
澳斯康生物完成4500万美元的A轮融资，以扩大一体化CMC，并在中国建设世界上最大的细胞培养生产厂
加州THOUSAND OAKS和上海 (美国商业资讯)– 澳斯康生物制药（海门）有限公司(Thousand Oaks Biopharmaceuticals,...
View Article